Pharmaceutical giant Johnson & Johnson has suspended all sales forecasts for its COVID-19 vaccine as demand for the shots is plummeting. The company cited a global supply surplus and uncertainty when it comes to future demand for the vaccine. J&J had previously predicted as much as $3.5 billion in 2022…
